Ceftazidime
Intravenous
Intramuscular
Class
Antibiotics
Subclass
Third-generation cephalosporins
Generic name
cefTAZidime
Brand names
Fortaz®
Common formulations
Powder for parenteral solution
Contained in
Ceftazidime / avibactam (Avycaz®)
Dosage and administration
Adults patients
Bacterial meningitis
Bone and joint infections
Gynecological infections • Serious
Hospital-acquired pneumonia
Intra-abdominal infections • Complicated
Lower respiratory tract infections in patients with immunocompromising conditions • Serious
Sepsis
SSTIs • Mild
UTIs • Uncomplicated cystitis
Ventilator-associated pneumonia
Bronchiectasis • Off-label
Native vertebral osteomyelitis • Off-label
Prosthetic joint infections • Caused by P. aeruginosa • Off-label
Other off-label uses
Indications for use
Labeled indications
Adults
Off-label indications
Adults
Safety risks
Contraindications
Hypersensitivity to ceftazidime or any of its components or other members of the cephalosporin class
Warnings and precautions
C. difficile infection
Seizure, nonconvulsive status epilepticus, encephalopathy, coma, asterixis
Specific populations
Renal impairment
eGFR 31-50 mL/min/1.73 m²
eGFR 16-30 mL/min/1.73 m²
eGFR 6-15 mL/min/1.73 m²
eGFR < 5 mL/min/1.73 m²
Renal replacement therapy
Continuous renal replacement
Intermittent hemodialysis
Peritoneal dialysis
Hepatic impairment
Any severity
Pregnancy and breastfeeding
Pregnancy
All trimesters • Australia Category: B1
Breastfeeding
Acceptable for use during breastfeeding.
Unknown drug levels in breastfed infants.
Adverse reactions
Common 1-10%
Unknown frequency
Interactions
Drug(s)
Check Interactions
Reset
What did you think about this content?
Sign up for free to access the full drug resource